Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -69.35% is in line with its 1-year average of -71.32%, around the middle of its 1-year range (-139.89%–-36.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.11% below its 12-month average of -68.59%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -69.35%.
RETURN ON INVESTED CAPITAL (ROIC)
-69.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-68.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.11%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 614 covered companies
CURRENT VS SECTOR MEDIAN
-107.73%
vs the sector median at left
MapLight Therapeutics, Inc.
Market Cap
$388.72M
Return on Invested Capital (ROIC)
-69.35%
TTM Avg
-68.59%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$383.60M
Return on Invested Capital (ROIC)
-3.55%
TTM Avg
-10.84%
3Y Avg
-10.87%
5Y Avg
-7.87%
Market Cap
$383.01M
Return on Invested Capital (ROIC)
-80.67%
TTM Avg
-59.31%
3Y Avg
-71.22%
5Y Avg
-64.55%
Market Cap
$380.42M
Return on Invested Capital (ROIC)
-54.07%
TTM Avg
-33.14%
3Y Avg
-21.50%
5Y Avg
-27.82%
Market Cap
$403.47M
Return on Invested Capital (ROIC)
-19.13%
TTM Avg
-11.02%
3Y Avg
-12.07%
5Y Avg
-13.96%
Market Cap
$371.16M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-10.82%
3Y Avg
-40.29%
5Y Avg
-33.17%
Market Cap
$406.69M
Return on Invested Capital (ROIC)
-36.54%
TTM Avg
-40.95%
3Y Avg
-100.88%
5Y Avg
-100.88%
Market Cap
$409.28M
Return on Invested Capital (ROIC)
-54.45%
TTM Avg
-31.52%
3Y Avg
-36.49%
5Y Avg
-36.90%
Market Cap
$410.54M
Return on Invested Capital (ROIC)
-89.93%
TTM Avg
-54.36%
3Y Avg
-39.52%
5Y Avg
-23.86%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $388.72M | -69.35% | -68.59% | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $383.60M | -3.55% | -10.84% | -10.87% | -7.87% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $383.01M | -80.67% | -59.31% | -71.22% | -64.55% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $380.42M | -54.07% | -33.14% | -21.50% | -27.82% |
| Myriad Genetics, Inc. (MYGN)vs › | $403.47M | -19.13% | -11.02% | -12.07% | -13.96% |
| Canopy Growth Corporation (CGC)vs › | $371.16M | -10.85% | -10.82% | -40.29% | -33.17% |
| Carlsmed, Inc. (CARL)vs › | $406.69M | -36.54% | -40.95% | -100.88% | -100.88% |
| Neurogene Inc. (NGNE)vs › | $409.28M | -54.45% | -31.52% | -36.49% | -36.90% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $410.54M | -89.93% | -54.36% | -39.52% | -23.86% |
| Shoulder Innovations, Inc. (SI)vs › | $411.45M | -25.26% | -29.12% | -26.65% | -26.65% |
ROIC
-69.4%
ROE
-66.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -69.35% |
| 2026-03-31 | -51.81% |
| 2025-12-31 | -36.43% |
| 2025-09-30 | -45.45% |
| 2025-06-30 | -139.89% |
| 2025-03-31 | -87.73% |
| 2024-12-31 | -68.55% |
